zonisamide + olanzapine + Zonisamide + Sugar Pill (placebo)
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Weight Gain
Conditions
Weight Gain
Trial Timeline
Jan 1, 2008 → Feb 1, 2011
NCT ID
NCT00363376About zonisamide + olanzapine + Zonisamide + Sugar Pill (placebo)
zonisamide + olanzapine + Zonisamide + Sugar Pill (placebo) is a phase 3 stage product being developed by Eli Lilly for Weight Gain. The current trial status is completed. This product is registered under clinical trial identifier NCT00363376. Target conditions include Weight Gain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00363376 | Phase 3 | Completed |
Competing Products
20 competing products in Weight Gain